Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways
The current study was aimed to evaluate the anti-proliferative activity of nobiletin, a flavonoid, on osteosarcoma cell line, SaOS-2. Furthermore, we attempted to investigate the signaling pathways involved in the cell growth inhibition mechanism. Upon exposure, nobiletin showed significant cell in...
Main Authors: | Fu-Wen Niu, Yong-Jie Zhang, Kun Li, Mao-Shu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Pharmacological Society
2014-09-01
|
Series: | Bangladesh Journal of Pharmacology |
Subjects: | |
Online Access: | https://www.banglajol.info/index.php/BJP/article/view/19567 |
Similar Items
-
Chemistry and bioactivity of nobiletin and its metabolites
by: Shiming Li, et al.
Published: (2014-01-01) -
Effect of nobiletin on experimental model of epilepsy
by: Yang Baowang, et al.
Published: (2018-12-01) -
Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways
by: Milad Ashrafizadeh, et al.
Published: (2020-05-01) -
Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention
by: Joanna Xuan Hui Goh, et al.
Published: (2019-06-01) -
Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis
by: Wang Y, et al.
Published: (2019-09-01)